Table of Contents Table of Contents
Previous Page  304 / 398 Next Page
Information
Show Menu
Previous Page 304 / 398 Next Page
Page Background

299

Relapse of multiple myeloma presenting as anaesthesia of

lower lip: a case report

Y. Al Riyami

∗

, A. Bakathir, K. Al Farsi, F. Al Azri

Oman Medical Specialty Board, Muscat, Oman

Multiple myeloma is a rare bone malignancy. It occurs exclu-

sively at medullary sites, and rarely at extramedullary locations.

Scientific literature search revealed few case reports describing

occurrence of multiple myeloma in the head and neck region as

primary manifestation of the disease. However, the occurrence of

relapse of multiple myeloma in these sites is exceedingly rare.

This poster describes a case of a-56-year old female with

past history of multiple myeloma that was treated by chemother-

apy and bone marrow transplant and was in remission state. Her

chief complaint was numbness of the lower lip of sudden onset.

Clinical and radiographic examination was suspicious of possible

relapse of multiple myeloma which was subsequently confirmed

by bone marrow aspirate and histopathological investigations.

This unique case highlights the important role of dental surgeons

encountering patients with malignancies. A thorough knowledge

of various clinical and radiographic manifestations of these dis-

eases is paramount to help in detecting any occurrence of the

disease or its relapse.

http://dx.doi.org/10.1016/j.ijom.2017.02.1005

Calcifying cystic odontogenic tumour with odontoma

formation: a case report and literature review

M. Apipi

∗

, P. Shanmuhasuntharam

University of Malaya, Kuala Lumpur, Malaysia

Calcifying cystic odontogenic tumour (CCOT) and odontoma are

two different entities which are classified as benign tumour of the

jaw. These tumours derived from epithelial, ectomesenchymal or

both the elements that have been part of the tooth-forming appa-

ratus. CCOT is rare in occurrences and uncommonly associated

with presence of odontoma.

We report a case of CCOT with odontoma formation at ante-

rior of maxilla region. A 19-year-old male patient was referred

to Oral and Maxillofacial Clinical Sciences, University Malaya

with incidental radiographic findings of a lesion at apical to

upper right incisors upon pre-orthodontic assessment. Dental

panoramic radiograph and cone beam computed tomography

revealed a multilocular radiolucency, well-delineated lesion con-

taining radiopaque masses located at apical to upper right incisors

region.

On intraoral examination, there was a bony hard bulge palpa-

ble palatal to upper right incisors with a normal overlying mucosa,

and also noted the upper right central incisor was rotated. Surgical

removal, enucleation of lesion shown a cystic lesion contained a

number of mineralised structure with some of it does appear as

small teeth. Histopathological examination confirmed the diag-

nosis of calcifying cystic odontogenic tumour with odontoma

formation. CCOT can be treated successfully with enucleation,

yet there are still chances of it to recur. This patient was reviewed

9 months later with no evidence of recurrence.

http://dx.doi.org/10.1016/j.ijom.2017.02.1006

Evaluation of genetic polymorphism of interleukin-1RN and

interleukin-1B in central giant cell lesion

N. Azevedo

∗

, I. Feijão, R. Cavalcante, S. Rabenhorst,

R. Osterne, R. Nogueira

Federal University of Ceará, Fortaleza, Brazil

Background:

Central giant cell lesion is an intraosseous lesion,

classified as aggressive and non-aggressive, of uncertain patho-

genesis, not existing agreement whether it is neoplastic or reactive,

but the proliferative activity was demonstrated in stromal cells,

suggesting the possibility of deregulation of the cell cycle in the

pathogenesis.

Objective:

Evaluate polymorphism of interleukin (IL)-1RN and

IL-1B

−

511C>T involved in inflammation in patients with this

pathology.

Methods:

The blood of 12 patients was collected. The presence

of polymorphismwas determined by DNA extraction, polymerase

chain reaction (PCR) and PCR-restriction fragment length poly-

morphism.

Findings:

Nine were females and three males, nine were aggres-

sive and three unaggressive, causing a ratio of 2:1 in the maxilla.

Among the 12 cases, 6 showed genotype L/L, 4 showed L/C and

two showed C/C to IL-1 RN. For IL-1B, three were T/T, five were

C/T and four were C/C. The IL 1RN C/C genotype was statis-

tically significant for females (

p

= 0.018). According to studies,

for the IL-1RN, the short allele with two replications shows more

aggressive clinical results in chronic inflammatory diseases. Long

alleles, on the other hand, with three or more replications, appear

to promote normal immune response. In the case of IL-1B, the

T/T genotype could be associated with greater risk.

Conclusion:

Cytokines may play a role in better understanding

of the pathogenesis and clinical behaviour, contributing to the

understanding of genetic susceptibility to injury. However, further

studies with larger sample relating other interleukins should be

performed to clarify these correlations.

http://dx.doi.org/10.1016/j.ijom.2017.02.1007

Immunohistochemistry evaluation of cyclin D1 and p16 in

central giant cell lesion

N. Azevedo

∗

, I. Feijão, R. Cavalcante, S. Rabenhorst,

R. Osterne, R. Nogueira

Federal University of Ceará, Fortaleza, Brazil

Background:

Central giant cells lesion (CGCL) is a benign

intraosseous pathology of the jaws, that affects mainly child and

young adults, occurring more in women than in men with prefer-

ence for the mandible. This pathology presents uncertain aetiology

and variable clinical behaviour thus it is important the develop-

ment of researches to determine its nature. The cyclin D1 and the

p16INK4a are markers of the cell cycle that have a well under-

standing of their relationship and association to ethiopathogenesis

of other tumours.

Objectives:

This study has the aim to evaluate the immunohis-

tochemistry expression of those markers in CGCL and correlate

with clinical findings.

Methods:

10 cases of CGCL were selected and underwent to

immunochemistry exam for cyclin D1 and p16INK4a so positive

and negative cells from both lines were counted.